Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Arezzo

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1992
Peripheral neuropathy induced by 2',3'-dideoxycytidine. A rabbit model of 2',3'-dideoxycytidine neurotoxicityT D Anderson, A Davidovich, R Arceo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2008
Novel neurosensory testing in cancer patients treated with the epothilone B analog, ixabepiloneS Goel, G L Goldberg, D Y-S Kuo, et al.
Journal of Pain and Symptom Management|February 1, 1991
Bilateral burning foot pain: monitoring of pain, sensation, and autonomic function during successful treatment with sympathetic blockadeB S Galer, R B Lipton, R Kaplan, et al.
Neurotoxicology|June 19, 2001
Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacyG Li, D A Frenz, S Brahmblatt, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 1994
Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicityT D Anderson, A Davidovich, D Feldman, et al.
Neurotoxicology|December 11, 1999
L- and D- methionine provide equivalent long term protection against CDDP-induced ototoxicity in vivo, with partial in vitro and in vivo retention of antineoplastic activityD Reser, M Rho, D Dewan, et al.
Annals of Internal Medicine|March 1, 1993
Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complexG Skowron, S A Bozzette, L Lim, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1992
Peripheral neuropathy induced by 2',3'-dideoxycytidine. A rabbit model of 2',3'-dideoxycytidine neurotoxicityT D Anderson, A Davidovich, R Arceo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2008
Novel neurosensory testing in cancer patients treated with the epothilone B analog, ixabepiloneS Goel, G L Goldberg, D Y-S Kuo, et al.
Journal of Pain and Symptom Management|February 1, 1991
Bilateral burning foot pain: monitoring of pain, sensation, and autonomic function during successful treatment with sympathetic blockadeB S Galer, R B Lipton, R Kaplan, et al.
Neurotoxicology|June 19, 2001
Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacyG Li, D A Frenz, S Brahmblatt, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 1994
Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicityT D Anderson, A Davidovich, D Feldman, et al.
Neurotoxicology|December 11, 1999
L- and D- methionine provide equivalent long term protection against CDDP-induced ototoxicity in vivo, with partial in vitro and in vivo retention of antineoplastic activityD Reser, M Rho, D Dewan, et al.
Annals of Internal Medicine|March 1, 1993
Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complexG Skowron, S A Bozzette, L Lim, et al.
Pageof 2